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he French concept of “psychose hallucinatoire
chronique” (PHC or chronic psychotic hallucinations)
is characterized by late-onset psychosis, predominantly
in females, with prominent and frequent hallucinations,
but almost no dissociative features.
1 In the 1920s, de
Clérambault stated that the syndrome of mental
automatism specifically characterized this psychotic dis-
order.
2,3 The distinction between schizophrenia and
chronic delusional syndromes (such as paraphrenia and
PHC) is currently used in France and was included in
Pull and Pichot’s classification in the 1980s,
4-6 although
there are no international criteria for these syndromes
(International Statistical Classification of Diseases, 10th
Revision
7 [ICD-10] or the Diagnostic and Statistical
Manual of Mental Disorders, 4th edition
8 [DSM-IV]).
The nosographic status of the nonaffective/organic psy-
chotic states arising in middle to late life has been sur-
rounded by controversy and uncertainty.Both Kraepelin
9
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The distinction between schizophrenia and chronic delusional syndromes (including the French concept of “psychose hal-
lucinatoire chronique” [PHC] or chronic psychotic hallucinations, paraphrenia, and late paraphrenia) is currently used in
various European countries, although there are no international criteria for chronic and bizarre delusions. The French
concept of PHC is characterized by late-onset psychosis, predominantly in females, with rich and frequent hallucinations,
but almost no dissociative features or negative symptoms. PHC and late-onset schizophrenia may have risk factors in com-
mon, which may help differentiate these disorders from young-onset schizophrenia, especially with regard to the
potential role of (i) the estradiol hypothesis; (ii) the impact of sensory deficit; (iii) putative specific brain abnormalities;
or (iv) specific genetic mutations. In accordance with this hypothesis, and taking into account the familial aggregation
analyses of PHC, here we evaluate the possibility that PHC represents a less severe form of schizophrenia, which would
partly explain the “Sherman paradox” also observed in schizophrenia. The Sherman paradox describes the fact that mul-
tiplex families frequently have only one affected ascendant, meaning that an isolated sporadic case is at the origin of a
highly loaded family. We thus propose that if unstable mutations are involved in the risk for schizophrenia, then PHC
might represent a moderate disorder belonging to the schizophrenia spectrum phenotype. 
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and Bleuler
10 described disease states resembling those
with an early onset,but which began at a more advanced
age in some cases. Nevertheless, in 1919, Kraepelin
described the concept of “paraphrenia,” which did not
have age boundaries, but rather distinguished a group of
patients with primary delusional symptoms, preservation
of personality,an impact on mood,and lack of deteriora-
tion, in contrast with dementia.
11 In 1943, Manfred
Bleuler coined the term “late-onset schizophrenia” to
describe a particular group of patients with onset of psy-
chosis after the age of 40 years and with less affective flat-
tening and less formal thought disorder.
12 These descrip-
tions are reminiscent of Kraepelin’s paraphrenia with
delusional syndrome and absence of disorganization or
deterioration.
Since the early emergence of geriatric psychiatry in the
1950s, the European literature on schizophrenia-like
symptoms with a late onset has been dominated by the
diagnosis of late paraphrenia.
13-19 In 1955, Roth defined
late paraphrenia as “a well-organized system of para-
noid delusions with or without auditory hallucinations
existing in the setting of a well-preserved personality
and affective response,” beginning after the age of 60
years.
14 Late paraphrenia distinguished the illness from
schizophrenia and emphasized its clinical similarities
with Kraepelin’s paraphrenic patients.This concept was
readily adopted and was included in ICD-9.
20
There is much debate in the literature as to whether late
paraphrenia represents cases of late-onset schizophre-
nia with an age at onset of over 60 years or is a variety
of disorders within which only a proportion of patients
fulfill the diagnostic criteria for schizophrenia.
15,17,21
Organic factors are often supposed to play an important
role in the initiation and maintenance of psychotic
symptoms in late-life psychoses.
15,16,18,22,23 In a review,
Harris and Jeste concluded that “late-onset schizophre-
nia is not a homogeneous entity but is a syndrome with
clinically and biologically relevant subtypes.”
24 The
absence of clear boundaries between PHC, late-onset
schizophrenia, and late paraphrenia leads to confusion
and limits comparisons of the various research findings.
The nosologic status of psychotic states arising in late
life is still debated. Recently, the International Late-
Onset Schizophrenia Group Consensus Conference
produced sufficient evidence to recognize two illness
classifications: late-onset schizophrenia (onset after age
40) and very-late-onset schizophrenia-like psychosis
(onset after age 60).
25
In the USA, the DSM-III-R Advisory Group acknowl-
edged the need to allow a separate category of “late-
onset”for patients whose illness began after age 44.This
decision was largely in reaction to the unsatisfactory
upper limit for age at onset that prevailed for a diagno-
sis of schizophrenia according to DSM-III.
17,26,27
However, both DSM-IV and ICD-10 have removed any
reference to the age at onset of symptoms for schizo-
phrenia or delusional disorder.
7,8 Through the European
or American literature, here we aim to clarify the posi-
tion of late-life psychosis and, more particularly, PHC.
We also give some results of a study that compared 30
female patients with PHC admitted consecutively in a
psychiatric setting and 30 female patients with schizo-
phrenia, matched for age at interview.
28 We assessed all
patients with a face-to-face psychiatric interview using
the Diagnostic Interview for Genetic Study (DIGS)
29
and the Family History—Research Diagnostic Criteria
(FH-RDC)
30 in order to detect presence of psychotic dis-
orders in the relatives of both groups.
Clinical aspects
Patients with PHC are often described as having been
reclusive,suspicious,and hostile throughout life.In France
in 1911,Ballet found abnormal personality traits in 80%
of patients with PHC.
1 This description shares common
characteristics with late paraphrenia.
14-16,31 However,some
patients have a good academic and employment record,
even if social isolation may frequently occur.
32 In a French
sample of 30 patients with PHC,the majority of patients
were married and had children, but half of them lived
alone at the beginning of the illness.
28The vast majority of
PHC patients were working or retired,in contrast to the
majority of the group of patients with schizophrenia,who
had a mentally handicapped status.
Age at onset of PHC in females is classically around
the menopause. While the majority of cases of PHC
begin after 30 years, Pull and Pichot did not base the
definition of this disorder on the age at onset, in con-
trast with the concepts of late-onset schizophrenia and
late paraphrenia.
4-6 In our study, the mean age at onset
of PHC was 50 years,ie,20 years older than in the schiz-
ophrenic groups.In this respect,the International Late-
Onset Schizophrenia Group Consensus Conference
emphasized that categorization by specific age-at-onset
ranges was relatively arbitrary with a proposed cutoff of
40, 45, 55, or 60 years.
25The PHC entity was mainly based on clinical character-
istics. PHC patients are more likely to have hallucina-
tions than schizophrenic patients,particularly when mul-
tiple sensory modalities are concerned. This clinical
picture shares common characteristics with late para-
phrenia,
14,15,19,33 or late-onset schizophrenia.
34,35 Specific hal-
lucinations including conversing voices, running com-
mentary auditory hallucinations, and thought echo are
characteristic of the PHC group.All these hallucinatory
experiences characterized the mental automatism
described by de Clérambault in 1924 for the isolation of
the concept of PHC,
2 and are a further important clinical
difference from cases of schizophrenia.The delusions in
PCH were also often well-systematized and fantastic,
with paranoid and persecutory content and the presence
of “partition delusions.” Persecution and ideas of refer-
ence are found in excess in the PHC group, consistent
with established features of late paraphrenia or late-
onset schizophrenia.
35 PHC patients are also more likely
than schizophrenic patients to complain about delusions
of being controlled and exposed to thought insertion.
These features characterized the “ideoverbal” automa-
tism described by de Clérambault and were particularly
important in the hallucinatory experiences in a variety of
sensory modalities for the first isolation of the concept of
PHC one century ago.The description of positive symp-
toms and, particularly, the kind of delusions and the
modality of hallucinations all share common aspects in
PHC,late paraphrenia,and late-onset schizophrenia.The
description seems to be more homogeneous and more
pronounced in PHC patients who have at least one kind
of hallucination and always have persecutory delusions.
Negative symptoms are very rare in the PHC group,while
they are much more frequently cited in schizophrenia,par-
ticularly for cases with an early onset. Pearlson observed
that the occurrence of negative symptoms increased with
duration of illness,and decreased with age at onset.
34These
findings are consistent with the idea that negative or deficit
symptoms are characteristic of an early-onset form of schiz-
ophrenia,
36 and are not detected in PHC.
PHC patients were initially described by the absence of for-
mal thought disorder, though in 1961 Kay and Roth
reported incoherence of speech,the use of neologisms,cir-
cumstantiality,or irrelevance in 30% of their patients with
late paraphrenia,
15 and Pearlson et al found thought disor-
der in 6% of patients with late-onset schizophrenia.
34 Formal
thought disorder may not exist in PHC,though it is consid-
ered to be a core feature of schizophrenia.
37,38
Risk factors
Brain imaging
Computed tomography and magnetic resonance imaging
studies have reported nonspecific structural changes
(higher ventricle/brain ratio, third ventricle volume) in
patients with late-onset psychosis compared with age-
matched controls.Studies on the density of dopamine D2
receptors (positron emission tomography [PET] or single
photon emission computed tomography [SPECT]) have
produced discrepant results.
39,40
Sensory deficit
Old age is often associated with reduced sensitivity and
acuity of taste,smell,touch,vision,and hearing.Although
both auditory (particularly long-standing conductive deaf-
ness) and visual deficits have been related to the devel-
opment of paranoid features in old age,
41 this observa-
tion may be explained by the reluctance of these patients
to seek corrective measures. However, reports of a sig-
nificant reduction in psychotic activity after a hearing aid
has been fitted indicate that deafness is,at least in part,a
predisposing factor for the development of symptoms,
even though it is difficult to explain such a complex dis-
order on the basis of a simple sensory deficit.
42
Gender and hormonal status
Practically all studies of late-onset schizophrenia and late
paraphrenia, or more particularly PHC, report a large
excess of affected women. Reported female/male ratios
range from 6:1
43 to 45:2
44; in one PHC group, Bénazet
found a 1:7 female/male ratio.
45
Seeman and Lang proposed that the higher level of
estrogen before the menopause might result in the
delayed onset of symptoms in women.
46 Pearlson et al
reported an increased density of D2 receptors in late-
onset schizophrenia,
39 although a recent attempt to
replicate this finding has failed.
47 Estrogens seem to
modulate the sensitivity of D2 receptors in brain and,
according to some authors,estrogens could have a neu-
roleptic-like effect.
48 Moreover, estrogens can reduce
the dopamine concentration in the striatum,
49 thereby
modulating the sensitivity and the number of dopamine
receptors.
50-52 Estrogens could thus act as a protective
factor, delaying the onset of the psychotic syndrome
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in women.The menopause could represent a high-risk
period in vulnerable women in terms of  loss of estrogen.
An alternative hypothesis is that, rather than the exis-
tence of a delaying factor detected in all female
patients, some vulnerability factors may be involved in
a subgroup of patients,with a particular range of age at
onset. For example, in a recent genetic analysis, we
observed a significant excess of one D2 receptor gene
haplotype in schizophrenic patients, specifically in a
subsample of patients with a disease onset occurring
after 20 years of age.
53
Another hypothesis is that significant vulnerability genes
are differentially expressed among generations, with a
milder form and late onset (such as PHC) in older gen-
erations,and a more severe disorder with younger age at
onset (such as schizophrenia) in younger generations.
Unstable mutations (Figure 1) can shed light on such
mechanisms.
54 If such mutations are involved,and if the
PHC phenotype is the milder form of the schizophrenia
spectrum disorder,we should observe a decreased risk in
ascendants (this is the Sherman paradox), and an
increased risk in descendants. This can be analyzed on
the basis of our 30 families with PHC.
Family history
Family, adoption, and twin studies suggest that there are
genetic factors in the risk for schizophrenia. The fre-
quency of schizophrenia in the relative of an affected
proband is close to 10%, compared with 1% in the gen-
eral population.
55 Unfortunately,the literature on familial
risk in PHC or late-onset schizophrenia is rather sparse,
partly because of the difficulty in conducting such family
studies in elderly patients who often have few surviving
relatives. Moreover, these studies often lack a method-
ological description for the identification of family mem-
bers and the definition of illness, including the age at
onset. Despite these limitations, the risk of schizophre-
nia in relatives of late-onset schizophrenic probands
ranges from 2.3%
44 to 9.8%
12 for siblings and from 0.0%
Figure 1. Expanded trinucleotide repeats, or unstable DNA, are the biological basis of the clinical phenomenon of genetic anticipation in different neu-
rodegenerative disorders, and could be involved in schizophrenia. Usually, the CAG (triplet) repeat is repeated a certain number of times, for
example, <6 times (yellow bar). It remains this length for life and generation after generation. In some disorders, a mutation occurs, which is
not explained by a deletion or a substitution of a nucleotide, but rather by a loss of control of the number of times a triplet is repeated. When
this number is above a certain cutoff (in this case, 42), then the expansion is no longer controlled, and will continue to expand in successive
generations, although the phenotype is not yet modified for subjects with moderate size expansion (orange bar). In the next generation, the
mutation is longer (the coded protein could be less functional), then, when a certain number of repetitions are observed (eg, 200 in this figure),
the disorder is present (red bar). In further generations, the mutation usually increases, explaining worsening severity and/or earlier age at onset
with each succeeding generation and accounting for the anticipation effect at the epidemiological level.
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12,56 Thus, it appears that the preva-
lence of  schizophrenia in the first-degree relatives of late-
onset schizophrenic probands is greater than in the gen-
eral population, but lower than in the first-degree
relatives of earlier-onset schizophrenic patients.
Previous studies showed a trend toward decreasing famil-
ial risk schizophrenia with increasing age at onset.
35 Some
reports have suggested the existence of a subgroup of
affected females with late onset and no family history of
schizophrenia.
57,58 In addition, later-onset illness is asso-
ciated with clinical peculiarities (intensity of delusions
and presence of multiple-sense hallucinations, rarity of
negative symptoms, or thought disorder) and a better
outcome.Only Bleuler and Post give data on age at onset
in relatives, making any definite conclusion difficult to
draw.
12,16
In our sample,we found that subjects with PHC had less
familial risk (6/501) compared with schizophrenic sub-
jects (17/418) (χ
2=7.70, df=1, P=0.006) (Table I).
28 This 
difference is mainly explained by the presence of less-
affected sibs in PHC patients compared with schizo-
phrenic patients (2/83 versus 9/78;χ
2=5.37,df=1,P=0.02)
and a tendency for less-affected ascendants (none versus
5/236). There were nearly equal numbers of affected
descendants (4/83 versus 3/78). Furthermore, we found
that age at onset was moderately correlated within fami-
lies (ρ =0.501, df=15, P=0.097), highly correlated within
sibships (ρ =0.629, df=24, P=0.004), but not corre-
lated throughout different generations within families 
(ρ =-0.389,df=16,P=0.22).
Subjects with PHC thus had less family history of schizo-
phrenia than the schizophrenic patients in our sample,
but were associated with an increased risk of an earlier
and more severe psychotic phenotype (ie,schizophrenia)
in descendants,without any detected case of PHC in the
relatives of the proband.This is compatible with the antic-
ipation effect,which has already been suggested for schiz-
ophrenia by many studies.
59-74
Anticipation describes an inheritance pattern within a
pedigree where disease severity increases or age at
onset decreases in successive generations. This phe-
nomenon has been described in nearly 20 neuropsychi-
atric disorders such as fragile X syndrome
75 and Hunt-
ington’s disease.
76 In these disorders, anticipation has
recently been shown to correlate with the expansion of
trinucleotide repeat sequences at the disease locus (Fig-
ure 1).T hese diseases represent a class of disorders
caused by unstable DNA sequences that can change in
each generation, accounting for anticipation. The dis-
covery in rapid succession of several diseases caused
by expansion of triplets raises the possibility that addi-
tional neuropsychiatric disorders with clinical features
of anticipation could be candidates.
77 The common
properties of these mutations are the departures from
mendelian inheritance and the highly variable pheno-
type with wide-ranging age at onset, which are well-
known characteristics of schizophrenia. More direct
analyses of the genome have been made in order to
detect large expansion of triplets in severe and early
forms of schizophrenia, with conflicting and, above all,
negative results.
78-96 The complexity of the methods
required to detect a specific unstable mutation,and the
clinical and genetic heterogeneity of schizophrenia,
probably explain the presence of many negative studies
and nonreplications of initially positive associations.On
the other hand, epidemiological evidence in favor of
anticipation can be considered as very good,because it
is based on many different samples and with numerous
different methodological strategies. Nevertheless, the
relationship between epidemiological anticipation and
unstable genes remains to be proven in schizophrenia.
Evidence for the anticipation effect is reinforced by the
presence of a correlation for age at onset within sibships
in our sample,with a younger age at onset in recent gen-
erations. If the PHC syndrome is considered as a mod-
erate form of schizophrenia (with moderate negative
Clinical research
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Table I. Schizophrenic morbidity in family members (first- and second-degree) of patients with chronic psychotic hallucinations (PHC) or schizophrenia.
Disorder of the proband
Relatives of patients with PHC Relatives of patients with schizophrenia
Type of relative Total Affected Total Affected
N (%) N (%)
Ascendants 253 0 (0.0) 236 5 ( 2.1)
Descendants 165 4 (2.4) 104 3 ( 2.9)
Sibships 83 2 (2.4) 78 9 (15.1)
Total 501 6 (1.2) 418 17 ( 4.3)Chronic psychotic hallucinations - Dubertret and Gorwood Dialogues in Clinical Neuroscience - Vol 3 .No.4 .2001
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El concepto francés de “psychose
hallucinatoire chronique”, ¿una forma
preliminar de esquizofrenia?
El papel de la psicosis tardía de la vida en la
hipótesis de la anticipación en la esquizofrenia
La distinción entre la esquizofrenia y los síndromes
delirantes crónicos (que incluyen el concepto francés
de “psychose hallucinatoire chronique”(PHC) o
psicosis alucinatoria crónica , la parafrenia y la para-
frenia tardía) se utiliza actualmente en varios países
europeos, a pesar de que no existen criterios inter-
nacionales para los delirios crónicos y bizarros. El con-
cepto francés de PHC está caracterizado por una psi-
cosis de aparición tardía, predominantemente en
mujeres, con alucinaciones intensas y frecuentes,
pero casi sin características disociativas o síntomas
negativos. La PHC y la esquizofrenia de aparición tar-
día pueden tener factores de riesgo en común, los
cuales pueden ayudar a diferenciar estos trastornos
de la esquizofrenia de aparición en la juventud, espe-
cialmente en relación con el potencial papel de: (1) la
hipótesis del estradiol, (2) el impacto del déficit sen-
sorial, (3) las posibles alteraciones cerebrales especí-
ficas o (4) las mutaciones genéticas específicas. De
acuerdo a esta hipótesis, y teniendo en cuenta el aná-
lisis de la agregación familiar de la PHC, nosotros eva-
luamos acá la posibilidad que la PHC represente una
forma menos severa de esquizofrenia, lo que podría
explicar en parte la “paradoja de Sherman”, que tam-
bién se observa en la esquizofrenia. La paradoja de
Sherman describe el hecho que familias con transmi-
sión de multiplex frecuentemente tienen sólo un
ascendiente afectado, lo que significa que un caso
esporádico aislado constituye el origen de una fami-
lia con una alta carga genética. Por esta razón es que
nosotros proponemos que si las mutaciones inesta-
bles están involucradas en el riesgo de esquizofrenia,
entonces la PHC podría representar un trastorno
moderado que pertenezca al fenotipo del espectro
de la esquizofrenia.
Le concept français de psychose
hallucinatoire chronique - forme
préliminaire de schizophrénie ?
Rôle de la psychose tardive dans l’hypothèse
d’anticipation de la schizophrénie 
La distinction entre la schizophrénie et les syn-
dromes de délire chronique (comprenant la psycho-
se hallucinatoire chronique [PHC] – concept français
– la paraphrénie et la paraphrénie tardive) est cou-
ramment utilisée dans divers pays européens, bien
qu’il n'existe pas de critères internationaux concer-
nant les délires chroniques et bizarres. Le concept
français de PHC est caractérisé par une psychose
d’apparition tardive, principalement féminine,
accompagnée d’hallucinations riches et fréquentes,
mais presque sans manifestation dissociative ni
symptôme négatif. La PHC et la schizophrénie d’ap-
parition tardive peuvent avoir des facteurs de
risque communs, pouvant aider à les différencier
des schizophrénies d’apparition précoce, particuliè-
rement en ce qui concerne le rôle potentiel : (1) de
l’hypothèse estrogénique ; (2) de l’impact du déficit
sensoriel ; (3) d'éventuelles anomalies cérébrales
spécifiques ; ou (4) de mutations génétiques spéci-
fiques. Partant de cette hypothèse, et tenant comp-
te des analyses d’agrégation familiale de la PHC,
nous discutons ici la possibilité que la PHC constitue
une forme moins sévère de schizophrénie, ce qui
expliquerait en partie le « paradoxe de Sherman »
observé également dans la schizophrénie. Ce para-
doxe se réfère à des familles multiplexes dans les-
quelles il n’y a souvent qu’un seul ascendant atteint,
ce qui signifie qu’un cas isolé sporadique est à l’ori-
gine d’une famille avec un lourd fardeau géné-
tique. Nous proposons donc, dans le cas où des
mutations instables seraient impliquées dans le
risque de schizophrénie, que la PHC représente un
trouble mineur faisant partie du phénotype du
spectre de la schizophrénie.  Chronic psychotic hallucinations - Dubertret and Gorwood Dialogues in Clinical Neuroscience - Vol 3 .No.4 .2001
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